RT Journal Article
SR Electronic
T1 Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A Report of 2 Cases
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.18.20232546
DO 10.1101/2020.11.18.20232546
A1 Mendes-Correa, Maria Cassia
A1 Leal, Fabio E.
A1 Villas-Boas, Lucy S.
A1 Witkin, Steven S.
A1 de Paula, Anderson
A1 Tozetto-Mendonza, Tania Regina
A1 Ferreira, Noely Evangelista
A1 Curty, Gislaine
A1 de Carvalho, Pedro Santos
A1 Buss, Lewis F.
A1 Costa, Silvia F.
A1 da Cunha Carvalho, Flavia Mendes
A1 Kawakami, Joyce
A1 Taniwaki, Noemi Nosomi
A1 Paiao, Heuder
A1 da Silva Bizário, Joao Carlos
A1 de Jesus, Jaqueline Goes
A1 Sabino, Ester Cerdeira
A1 Romano, Camila Malta
A1 Zetone Grepan, Regina Maura
A1 Sesso, Antonio
YR 2020
UL http://medrxiv.org/content/early/2020/11/20/2020.11.18.20232546.abstract
AB It has been estimated that individuals with COVID-19 can shed replication-competent virus up to a maximum of twenty days after initiation of symptoms. This report describes two patients with mild forms of the disease who shed replication-competent virus for 24 and 37 days, respectively, after symptom onset.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthors involved in the manuscript or study design did not receive any kind oy payment for their service. The study was funded by Virology Laboratory from Instituto de Medicina Tropical-Faculdade de Medicina da Universidade de Sao Paulo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local ethics committee (Comissao de Etica para Analise de Projeto de Pesquisa - CAPPesq, protocol No. 13915, dated June 03, 2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is avaiable for consultation at any time.